Kraj: Malta
Język: angielski
Źródło: Medicines Authority
DIPHTHERIA TOXOID, TETANUS TOXOID
IBSS Biomed S.A. AL. Sosnowa 8, 30-224 Krakow, Poland
J07AM51
DIPHTHERIA TOXOID 5 IU TETANUS TOXOID 40 IU
SUSPENSION FOR INJECTION
DIPHTHERIA TOXOID 5 IU TETANUS TOXOID 40 IU
POM
VACCINES
Licence number in the source country: Poland - R/0038
Authorised
2012-09-06
7U004E 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CLODIVAC, suspension for injection Diphtheria and tetanus vaccine, adsorbed, reduced antigen content Not less than 40 IU of tetanus toxoid and not less than 5 IU of diphtheria toxoid/0.5 ml; 1 dose (0.5 ml) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS VACCINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. This vaccine has been prescribed for you only. Do not pass it on to others. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Clodivac is and what it is used for 2. What do you need to know before you use Clodivac 3. How to use Clodivac 4. Possible side effects 5. How to store Clodivac 6. Contents of the pack and other information 1. WHAT CLODIVAC IS AND WHAT IT IS USED FOR Clodivac is a vaccine used to protect against two diseases: tetanus and diphtheria caused by _Clostridium tetani_ and _Corynebacterium diphtheriae. _Active substances of the vaccine are tetanus toxoid and diphtheria toxoid (non-infectious components derived from bacteria). After vaccine administration the organism produces antibodies to protect against these diseases. The vaccine is used for active immunisation of children over 7 years of age, adolescents and adults against tetanus and diphtheria. _ _ Basic vaccination individuals over 7 years of age who have not received the basic vaccination against diphtheria and tetanus (i.e. mandatory vaccination according to the National Immunization Program). Booster vaccination children over 7 years of age who have not received booster dose of DTPa at the age of 6 (in case of contraindication for pertussis vaccination) adolescents at age of 14 and 19, adults who received a complete course of basic vaccination against tetanus and diphtheria (bo Przeczytaj cały dokument